U.S. In-vitro Diagnostics Market Size, Share & COVID-19 Impact Analysis, By Product Type (Instruments and Reagents & Consumables), By Technique (Immunodiagnostics, Clinical Chemistry, Molecular Diagnostics, Hematology, and Others), By Setting (Laboratories and Point of Care), By Application (Infectious Diseases, Cardiology, Oncology, Gastroenterology, and Others), By End-user (Clinical Laboratories, Hospitals, Physician’s Offices, and Others), and Forecasts, 2023-2030

Last Updated: November 17, 2025 | Format: PDF | Report ID: FBI107584

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

Schedule a 30 minutes session to understand our consulting capabilities – SCHEDULE NOW

Table of Content

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Prevalence of Key Diseases in the U.S., 2021/2022
2. New Product Launches by Key Players
3. Recent Industry Developments - Mergers & Acquisitions
4. Overview of Healthcare Expenditure in the U.S.
5. Technological Advancements
6. Key Industry Trends
7. Impact of COVID-19 on the In-Vitro Diagnostics Market
U.S. In-Vitro Diagnostics Market Analysis, Insights and Forecast, 2019-2030
1. Market Analysis, Insights and Forecast – By Product Type
  1. Instruments
  2. Reagents & Consumables
2. Market Analysis, Insights and Forecast – By Technique
  1. Immunodiagnostics
  2. Clinical Chemistry
  3. Molecular Diagnostics
  4. Hematology
  5. Others
3. Market Analysis, Insights and Forecast – By Setting
  1. Laboratories
  2. Point of care
4. Market Analysis, Insights and Forecast – By Application
  1. Infectious Diseases
  2. Cardiology
  3. Oncology
  4. Gastroenterology
  5. Others
5. Market Analysis, Insights and Forecast – By End User
  1. Clinical Laboratories
  2. Hospitals
  3. Physicians Offices
  4. Others
Competitive Analysis
1. U.S. Market Share Analysis (2022)
2. Company Profiles (Overview, Product, SWOT Analysis, Recent Developments, Strategies, financials (Based on Availability))
  1. Abbott
    1. Overview,
    2. Product,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. financials (Based on Availability)
  2. F. Hoffmann-La Roche AG
    1. Overview,
    2. Product,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. financials (Based on Availability)
  3. Thermo Fisher Scientific Inc.
    1. Overview,
    2. Product,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. financials (Based on Availability)
  4. Quest Diagnostics Incorporated
    1. Overview,
    2. Product,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. financials (Based on Availability)
  5. Bio Rad Laboratories, Inc.
    1. Overview,
    2. Product,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. financials (Based on Availability)
  6. BD
    1. Overview,
    2. Product,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. financials (Based on Availability)
  7. Agilent Technologies, Inc.
    1. Overview,
    2. Product,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. financials (Based on Availability)
  8. Quidel Corporation
    1. Overview,
    2. Product,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. financials (Based on Availability)
  9. Siemens Healthcare GmbH
    1. Overview,
    2. Product,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. financials (Based on Availability)

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Prevalence of Key Diseases in the U.S., 2021/2022
2. New Product Launches by Key Players
3. Recent Industry Developments - Mergers & Acquisitions
4. Overview of Healthcare Expenditure in the U.S.
5. Technological Advancements
6. Key Industry Trends
7. Impact of COVID-19 on the In-Vitro Diagnostics Market
U.S. In-Vitro Diagnostics Market Analysis, Insights and Forecast, 2019-2030
1. Market Analysis, Insights and Forecast – By Product Type
  1. Instruments
  2. Reagents & Consumables
2. Market Analysis, Insights and Forecast – By Technique
  1. Immunodiagnostics
  2. Clinical Chemistry
  3. Molecular Diagnostics
  4. Hematology
  5. Others
3. Market Analysis, Insights and Forecast – By Setting
  1. Laboratories
  2. Point of care
4. Market Analysis, Insights and Forecast – By Application
  1. Infectious Diseases
  2. Cardiology
  3. Oncology
  4. Gastroenterology
  5. Others
5. Market Analysis, Insights and Forecast – By End User
  1. Clinical Laboratories
  2. Hospitals
  3. Physicians Offices
  4. Others
Competitive Analysis
1. U.S. Market Share Analysis (2022)
2. Company Profiles (Overview, Product, SWOT Analysis, Recent Developments, Strategies, financials (Based on Availability))
  1. Abbott
    1. Overview,
    2. Product,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. financials (Based on Availability)
  2. F. Hoffmann-La Roche AG
    1. Overview,
    2. Product,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. financials (Based on Availability)
  3. Thermo Fisher Scientific Inc.
    1. Overview,
    2. Product,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. financials (Based on Availability)
  4. Quest Diagnostics Incorporated
    1. Overview,
    2. Product,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. financials (Based on Availability)
  5. Bio Rad Laboratories, Inc.
    1. Overview,
    2. Product,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. financials (Based on Availability)
  6. BD
    1. Overview,
    2. Product,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. financials (Based on Availability)
  7. Agilent Technologies, Inc.
    1. Overview,
    2. Product,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. financials (Based on Availability)
  8. Quidel Corporation
    1. Overview,
    2. Product,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. financials (Based on Availability)
  9. Siemens Healthcare GmbH
    1. Overview,
    2. Product,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. financials (Based on Availability)

Read Less

List of Figures

Figure 1: U.S. In-Vitro Diagnostics Market Value Share (%), by Product Type, 2022 & 2030

Figure 2: U.S. In-Vitro Diagnostics Market Value Share (%), by Technique, 2022 & 2030

Figure 3: U.S. In-Vitro Diagnostics Market Value Share (%), by Setting, 2022 & 2030

Figure 4: U.S. In-Vitro Diagnostics Market Value Share (%), by Application, 2022 & 2030

Figure 5: U.S. In-Vitro Diagnostics Market Value Share (%), by End-user, 2022 & 2030

Figure 6: U.S. In-Vitro Diagnostics Market Share (%), By Company, 2022

List of Tables

Table 1: U.S. In-Vitro Diagnostics Market Revenue (USD billion) Forecast, by Product Type, 2019–2030

Table 2: U.S. In-Vitro Diagnostics Market Revenue (USD billion) Forecast, by Technique, 2019–2030

Table 3: U.S. In-Vitro Diagnostics Market Revenue (USD billion) Forecast, by Setting, 2019–2030

Table 4: U.S. In-Vitro Diagnostics Market Revenue (USD billion) Forecast, by Application, 2019–2030

Table 5: U.S. In-Vitro Diagnostics Market Revenue (USD billion) Forecast, by End-user 2019–2030

STUDY PERIOD: 2019-2030
BASE YEAR: 2022
HISTORICAL DATA: 2019-2021
NO OF PAGES: 160

Buy Now

Download Free Sample

Security Code

Growth Advisory Services

Clients

Related Reports

Get In Touch With Us

US +1 833 909 2966 ( Toll Free )

UK +44 808 502 0280 ( Toll Free )

+91 744 740 1245 (APAC)
sales@fortunebusinessinsights.com